PTC Therapeutics, Inc. (NasdaqGS:PTCT), Dillard’s, Inc. (NYSE:DDS) Stock Analysis & Valuation Update

PTC Therapeutics, Inc. (NasdaqGS:PTCT) has a Q.i. Value of 65.00000. The purpose of the Q.i. Value is to help identify companies that are the most undervalued. Typically, the lower the value, the more undervalued the company tends to be. The Q.i. Value ranks companies using four ratios. These ratios consist of EBITDA Yield, FCF Yield, Liquidity, and Earnings Yield. 

Individual investors have a lot to study when dealing with the stock market. New investors may start out thinking that with enough capital, they can easily start securing substantial gains. While equity market investing can help individuals build wealth, it can also be highly risky. Market education may be an extremely important part of any investor’s game plan. Knowing exactly where the money is invested and why it is invested there, may be a big help when reviewing portfolio performance down the line. Any investor who takes the reins and decides to make their own decisions should realize the importance of a well-rounded stock market education.

Checking in on some valuation rankings, PTC Therapeutics, Inc. (NasdaqGS:PTCT) has a Value Composite score of 83. Developed by James O’Shaughnessy, the VC score uses five valuation ratios. These ratios are price to earnings, price to cash flow, EBITDA to EV, price to book value, and price to sales.

The VC is displayed as a number between 1 and 100. In general, a company with a score closer to 0 would be seen as undervalued, and a score closer to 100 would indicate an overvalued company. Adding a sixth ratio, shareholder yield, we can view the Value Composite 2 score which is currently sitting at 87.

When dealing with the volatility and unpredictability of the stock market, investors may have to learn how to deal with their emotions. There are many factors that can have a big impact on the portfolio. Maintaining discipline can be one of the most important factors. From time to time, investors will be overcome by fear during a large market selloff. On the other side, investors may become extremely excited during a widespread market move to the upside. When these situations occur, investors tend to make better decisions if they are able to keep emotions out of play and stick to the original plan. Buying and selling at the wrong time can lead to portfolio underperformance, and it may damage investor confidence in the future.

We can now take a quick look at some historical stock price index data. PTC Therapeutics, Inc. (NasdaqGS:PTCT) presently has a 10 month price index of 1.01263. The price index is calculated by dividing the current share price by the share price ten months ago. A ratio over one indicates an increase in share price over the period. A ratio lower than one shows that the price has decreased over that time period.

PTC Therapeutics, Inc. (NasdaqGS:PTCT) has a current ERP5 Rank of 16238. The ERP5 Rank may assist investors with spotting companies that are undervalued. This ranking uses four ratios. These ratios are Earnings Yield, ROIC, Price to Book, and 5 year average ROIC. When looking at the ERP5 ranking, it is generally considered the lower the value, the better.

Looking at some alternate time periods, the 12 month price index is 1.37591, the 24 month is 3.20800, and the 36 month is 4.75494. Narrowing in a bit closer, the 5 month price index is 1.12500, the 3 month is 1.09297, and the 1 month is currently 0.95552.

Watching some historical volatility numbers on shares of PTC Therapeutics, Inc. (NasdaqGS:PTCT), we can see that the 12 month volatility is presently 50.903900. The 6 month volatility is 53.798200, and the 3 month is spotted at 45.426100.

Key Ratios

Turning to some key ratios, PTC Therapeutics, Inc. (NasdaqGS:PTCT)’s Leverage Ratio was recently noted as 0.202550. This ratio is calculated by dividing total debt by total assets plus total assets previous year, divided by two. The leverage of a company is relative to the amount of debt on the balance sheet. This ratio is often viewed as one measure of the financial health of a firm.

PTC Therapeutics, Inc. (NasdaqGS:PTCT) presently has a current ratio of 1.92. The current ratio, also known as the working capital ratio, is a liquidity ratio that displays the proportion of current assets of a business relative to the current liabilities. The ratio is simply calculated by dividing current liabilities by current assets. The ratio may be used to provide an idea of the ability of a certain company to pay back its liabilities with assets. Typically, the higher the current ratio the better, as the company may be more capable of paying back its obligations.

The price to book ratio or market to book ratio for PTC Therapeutics, Inc. (NasdaqGS:PTCT) currently stands at 6.009566.  The ratio is calculated by dividing the stock price per share by the book value per share.  This ratio is used to determine how the market values the equity.  A ratio of under 1 typically indicates that the shares are undervalued.  A ratio over 1 indicates that the market is willing to pay more for the shares.  There are often many underlying factors that come into play with the Price to Book ratio so all additional metrics should be considered as well. 

Ever wonder how investors predict positive share price momentum?  The Cross SMA 50/200, also known as the “Golden Cross” is the fifty day moving average divided by the two hundred day moving average.  The SMA 50/200 for PTC Therapeutics, Inc. (NasdaqGS:PTCT) is currently 0.97405.  If the Golden Cross is greater than 1, then the 50 day moving average is above the 200 day moving average – indicating a positive share price momentum.  If the Golden Cross is less than 1, then the 50 day moving average is below the 200 day moving average, indicating that the price might drop.

C Score (Montier)

The C-Score is a system developed by James Montier that helps determine whether a company is involved in falsifying their financial statements. The C-Score is calculated by a variety of items, including a growing difference in net income verse cash flow, increasing days outstanding, growing days sales of inventory, increasing assets to sales, declines in depreciation, and high total asset growth. The C-Score of PTC Therapeutics, Inc. (NasdaqGS:PTCT) is 3.00000. The score ranges on a scale of -1 to 6. If the score is -1, then there is not enough information to determine the C-Score. If the number is at zero (0) then there is no evidence of fraudulent book cooking, whereas a number of 6 indicates a high likelihood of fraudulent activity. The C-Score assists investors in assessing the likelihood of a company cheating in the books.

When it comes to investing in stocks, the question of risk will eventually need to be addressed. Of course, there are no guarantees when investing in the stock market. With this in mind, investors can proceed with a plan that helps minimize risk while still providing the opportunity to experience large profit potential. Each investor may have a different financial situation or tolerance for risk. There is often a fine line between being too aggressive or too conservative with equity investments. Finding that balance between the two extremes may be exactly what the earnest investor strives to do when tackling the markets.

Dillard’s, Inc. (NYSE:DDS) has a Q.i. Value of 12.00000. The Q.i. Value ranks companies using four ratios. These ratios consist of EBITDA Yield, FCF Yield, Liquidity, and Earnings Yield. The purpose of the Q.i. Value is to help identify companies that are the most undervalued. Typically, the lower the value, the more undervalued the company tends to be.

The investing community is always using the terms bulls and bears. They are terms used to label market trends. Upward trends are considered bullish while downward trends are considered bearish. The overall market trend has been bullish for a long period of time. Trends can be long-term, short-term, or intermediate. These terms are used universally and may apply to entire markets or specific stocks. While there is money to be made in bull and bear markets, investors may want to concoct a stock strategy that will perform well during any conditions. Investors who are successful throughout any market conditions are typically highly focused, disciplined, and consistent with their trading maneuvers. Whether optimism or pessimism rules the sentiment, investors need to be able to capitalize when the time comes.

Checking in on some valuation rankings, Dillard’s, Inc. (NYSE:DDS) has a Value Composite score of 5. Developed by James O’Shaughnessy, the VC score uses five valuation ratios. These ratios are price to earnings, price to cash flow, EBITDA to EV, price to book value, and price to sales. The VC is displayed as a number between 1 and 100. In general, a company with a score closer to 0 would be seen as undervalued, and a score closer to 100 would indicate an overvalued company. Adding a sixth ratio, shareholder yield, we can view the Value Composite 2 score which is currently sitting at 2.

Watching some historical volatility numbers on shares of Dillard’s, Inc. (NYSE:DDS), we can see that the 12 month volatility is presently 44.726100. The 6 month volatility is 49.875400, and the 3 month is spotted at 45.426100. Following volatility data can help measure how much the stock price has fluctuated over the specified time period. Although past volatility action may help project future stock volatility, it may also be vastly different when taking into account other factors that may be driving price action during the measured time period.

Dillard’s, Inc. (NYSE:DDS) has a current ERP5 Rank of 3112. The ERP5 Rank may assist investors with spotting companies that are undervalued. This ranking uses four ratios. These ratios are Earnings Yield, ROIC, Price to Book, and 5 year average ROIC. When looking at the ERP5 ranking, it is generally considered the lower the value, the better.

We can now take a quick look at some historical stock price index data. Dillard’s, Inc. (NYSE:DDS) presently has a 10 month price index of 0.76706. The price index is calculated by dividing the current share price by the share price ten months ago. A ratio over one indicates an increase in share price over the period. A ratio lower than one shows that the price has decreased over that time period. Looking at some alternate time periods, the 12 month price index is 1.02342, the 24 month is 1.36092, and the 36 month is 1.02001. Narrowing in a bit closer, the 5 month price index is 1.18260, the 3 month is 1.16593, and the 1 month is currently 1.02182.

Return on Assets

There are many different tools to determine whether a company is profitable or not. One of the most popular ratios is the “Return on Assets” (aka ROA). This score indicates how profitable a company is relative to its total assets. The Return on Assets for Dillard’s, Inc. (NYSE:DDS) is 0.046233. This number is calculated by dividing net income after tax by the company’s total assets. A company that manages their assets well will have a higher return, while a company that manages their assets poorly will have a lower return.

Return on Invested Capital (ROIC), ROIC Quality, ROIC 5 Year Average

The Return on Invested Capital (aka ROIC) for Dillard’s, Inc. (NYSE:DDS) is 0.104302. The Return on Invested Capital is a ratio that determines whether a company is profitable or not. It tells investors how well a company is turning their capital into profits. The ROIC is calculated by dividing the net operating profit (or EBIT) by the employed capital. The employed capital is calculated by subrating current liabilities from total assets. Similarly, the Return on Invested Capital Quality ratio is a tool in evaluating the quality of a company’s ROIC over the course of five years. The ROIC Quality of Dillard’s, Inc. (NYSE:DDS) is 10.038700. This is calculated by dividing the five year average ROIC by the Standard Deviation of the 5 year ROIC. The ROIC 5 year average is calculated using the five year average EBIT, five year average (net working capital and net fixed assets). The ROIC 5 year average of Dillard’s, Inc. (NYSE:DDS) is 0.142980.

FCF Yield 5yr Avg

The FCF Yield 5yr Average is calculated by taking the five year average free cash flow of a company, and dividing it by the current enterprise value. Enterprise Value is calculated by taking the market capitalization plus debt, minority interest and preferred shares, minus total cash and cash equivalents. The average FCF of a company is determined by looking at the cash generated by operations of the company. The Free Cash Flow Yield 5 Year Average of Dillard’s, Inc. (NYSE:DDS) is 0.135725.

Gross Margin score

Investors may be interested in viewing the Gross Margin score on shares of Dillard’s, Inc. (NYSE:DDS). The name currently has a score of 6.00000. This score is derived from the Gross Margin (Marx) stability and growth over the previous eight years. The Gross Margin score lands on a scale from 1 to 100 where a score of 1 would be considered positive, and a score of 100 would be seen as negative.

As most investors realize, markets will trade in cycles. This being the case, most investors will likely experience extremes of both bull and bear markets during their investing tenure. A big factor in scooping up profits during bull or bear markets is having the ability to identify when markets are beginning to peak or bottom out. This is obviously no easy task even for the most experienced investor. Certain types of stock investment strategies may do better during different market conditions. Professional traders may use highly complex systems in order to spot market opportunities. Novice investors who are just starting out may use simple strategies at first. Choosing a stock picking strategy that is tailored to fit the individual investor’s goals and financial situation may be a good way to create a solid base from which to start from. With the proper amount of research and discipline, the novice investor can begin to make the transition into becoming a skilled investor.